IL102500A - History of 3-deoxy-monosamine, their preparation and pharmaceutical preparations containing them - Google Patents

History of 3-deoxy-monosamine, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL102500A
IL102500A IL10250092A IL10250092A IL102500A IL 102500 A IL102500 A IL 102500A IL 10250092 A IL10250092 A IL 10250092A IL 10250092 A IL10250092 A IL 10250092A IL 102500 A IL102500 A IL 102500A
Authority
IL
Israel
Prior art keywords
mannopyranose
dideoxy
compound
formula
acetamido
Prior art date
Application number
IL10250092A
Other languages
English (en)
Hebrew (he)
Other versions
IL102500A0 (en
Inventor
Nicola Mongelli
Alberto Bargiotti
Nuccia Oneto
Cristina Geroni
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IL102500A0 publication Critical patent/IL102500A0/xx
Publication of IL102500A publication Critical patent/IL102500A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL10250092A 1991-08-06 1992-07-15 History of 3-deoxy-monosamine, their preparation and pharmaceutical preparations containing them IL102500A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116896A GB9116896D0 (en) 1991-08-06 1991-08-06 3-deoxymannosamine derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
IL102500A0 IL102500A0 (en) 1993-01-14
IL102500A true IL102500A (en) 1996-01-19

Family

ID=10699545

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10250092A IL102500A (en) 1991-08-06 1992-07-15 History of 3-deoxy-monosamine, their preparation and pharmaceutical preparations containing them

Country Status (16)

Country Link
US (1) US5332756A (de)
EP (1) EP0527042A2 (de)
JP (1) JPH05208988A (de)
KR (1) KR930004325A (de)
AU (1) AU646173B2 (de)
CA (1) CA2075336A1 (de)
FI (1) FI923498A (de)
GB (1) GB9116896D0 (de)
HU (1) HU213208B (de)
IL (1) IL102500A (de)
MX (1) MX9204395A (de)
MY (1) MY108749A (de)
NZ (1) NZ243627A (de)
RU (1) RU2099333C1 (de)
TW (1) TW248564B (de)
ZA (1) ZA925871B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
FR2723947B1 (fr) * 1994-08-31 1996-09-27 Adir Nouveaux composes tetrahydropyraniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4943839B2 (ja) * 2004-05-26 2012-05-30 株式会社希少糖生産技術研究所 血管新生抑制剤
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
KR20070060069A (ko) * 2004-06-23 2007-06-12 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 다당류 유도체 및 면역반응의 유도에서의 용도
EP2001487A4 (de) * 2006-03-15 2010-09-15 Tufts College Fluorinierte kohlenhydrate und ihre verwendung bei der visualisierung von tumoren, bei der gewebebehandlung und bei der krebs-chemotherapie
KR100780868B1 (ko) 2006-07-10 2007-11-30 부경대학교 산학협력단 항암효과를 나타내는 4급 아미노 글루코사민 화합물
US8999954B2 (en) * 2007-07-03 2015-04-07 Childern's Hospital & Research Center at Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
CA2690440A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
CA2692417C (en) 2007-07-03 2017-03-21 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
FR2930943B1 (fr) * 2008-05-07 2011-03-18 Centre Nat Rech Scient Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216208A (en) * 1978-07-31 1980-08-05 Proter S.P.A. N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
DE3906174A1 (de) * 1989-02-28 1990-08-30 Forschungszentrum Juelich Gmbh Verfahren zur herstellung von d-mannosaminderivaten

Also Published As

Publication number Publication date
AU2037492A (en) 1993-02-11
FI923498A (fi) 1993-02-07
FI923498A0 (fi) 1992-08-03
EP0527042A3 (de) 1994-01-05
GB9116896D0 (en) 1991-09-18
NZ243627A (en) 1994-04-27
IL102500A0 (en) 1993-01-14
EP0527042A2 (de) 1993-02-10
KR930004325A (ko) 1993-03-22
MY108749A (en) 1996-11-30
CA2075336A1 (en) 1993-02-07
MX9204395A (es) 1993-02-01
TW248564B (de) 1995-06-01
HU213208B (en) 1997-03-28
US5332756A (en) 1994-07-26
HUT62593A (en) 1993-05-28
HU9202329D0 (en) 1992-10-28
JPH05208988A (ja) 1993-08-20
AU646173B2 (en) 1994-02-10
RU2099333C1 (ru) 1997-12-20
ZA925871B (en) 1993-04-28

Similar Documents

Publication Publication Date Title
IL102500A (en) History of 3-deoxy-monosamine, their preparation and pharmaceutical preparations containing them
JPH0660191B2 (ja) 新規アントラサイクリングリコシド類，それらの製造方法及びそれらを含む抗腫瘍剤
US4275192A (en) Bis(4-demethoxydaunorubicin)dihydrazone derivatives and pharmacologically acceptable salts thereof
JP4105258B2 (ja) コレスタノール化合物及びこれを含有する医薬
US5514658A (en) Oligosaccharides for inhibiting the mitosis of astrocytes and tumoral cells of the nervous system, and methods for obtaining them
US5220002A (en) Deacetylcolchicine derivatives
EP1057825A1 (de) Isoflavanderivate und immunverstärkende zusammensetzungen die diese enthalten
EP2041153B1 (de) Neue 5-thioxylpyranose-derivate
US5672757A (en) N-methyldeacetylcolchiceinamide derivatives
EP3750905A1 (de) Salz einer pyranose-substituierten heterocyclischen verbindung, verfahren zu ihrer herstellung und ihre verwendung
CN111825608A (zh) 四氢喹啉类与四氢异喹啉类化合物及其用途
JPS632279B2 (de)
US5958889A (en) Anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group
WO1997049433A1 (en) Fluoro labelled anthracyclinone and anthracycline derivatives
EP3061765B1 (de) Protoescigenin-Derivat, Verfahren zu seiner Herstellung, Verwendung dieser Verbindung und pharmazeutische Zusammensetzung mit dieser Verbindung
AU2523501A (en) Benzophenone glycopyranosides, preparation and therapeutic use
CN118027120A (zh) 糖基化修饰的二苯甲酮类化合物及其应用
EP0367671A2 (de) Beta-D-phenylthioxyloside, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CN118344425A (zh) 多羟基五环三萜类化合物及其制备方法和应用
CN115710253A (zh) 一类含有氨基苯并咪唑类衍生物及其制备和用途
JPH05163292A (ja) ３’及び／又は４’位の水酸基を化学修飾したエルサマイシンａ誘導体の製造法
EP1240177B1 (de) Benzophenon alpha-glycopyranoside, herstellung und therapeutische verwendung
US4960758A (en) Novel β-D-phenylthioxylosides, their method of preparation and their use as pharmaceuticals
鶴見膠一 et al. L-Serine from D-Glucosamine
CN113773356A (zh) 一种胡黄连苷ii衍生物及其制备方法和应用

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void